» Articles » PMID: 1117420

Brain Concentration of Propranolol in Relation to Hypotensive Effect in the Rabbit with Observations on Brain Propranolol Levels in Man

Overview
Specialty Pharmacology
Date 1975 Feb 1
PMID 1117420
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Intracerebroventricular (ICV) injection of propranolol in the dog, cat and rabbit produces a significant fall in arterial pressure. In the following experiments, regional brain propranolol concentrations and changes in mean arterial pressure (MAP) have been measured in the rabbit after central and peripheral administration of the drug and the results compared to human brain/plasma levels. In the conscious rabbit, ICV injection of l-propranolol (500 mug) produced a prolonged fall in MAP, maximal at 105 minutes (16.8 plus or minus 5.9 mm Hg below base line). The regional brain propranolol concentrations after ICV injection of 14C-dl-propranolol (530 mug) were determined and the levels compared to those achieved following i.v. infusion of the unlabeled drug (1.0 and 2.0 mg/kg/hr). The propranolol concentrations in the hypothalamus, medulla pons and midbrain after i.v. infusion were similar to the propranolol content in these areas at 60 and 120 minutes after ICV injection. Intravenous infusion of propranolol also resulted in significant falls in MAP between 60 and 120 minutes. In control studies, infusions of d-propranolol (1.0, 2.0 and 4.0 mg/kg/hr), which is virtually devoid of beta adrenoceptor blocking activity, produced only slight reductions in MAP. Postmortem studies in patients treated with prolonged i.v. infusions of d-propranolol as part of the treatment of paraquat poisoning indicate that the brain/plasma concentration of propranolol in man is similar to that observed in the rabbit. Propranolol is therefore highly concentrated in human brain tissue and comparable brain levels in the rabbit result in a hypotensive response.

Citing Articles

Increase in stable isotope ratios driven by metabolic alterations in amphipods exposed to the beta-blocker propranolol.

Ek C, Garbaras A, Yu Z, Oskarsson H, Eriksson Wiklund A, Kumblad L PLoS One. 2019; 14(5):e0211304.

PMID: 31095563 PMC: 6522046. DOI: 10.1371/journal.pone.0211304.


The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain.

Takahashi H, Yoshika M, Komiyama Y, Nishimura M Hypertens Res. 2011; 34(11):1147-60.

PMID: 21814209 PMC: 3324327. DOI: 10.1038/hr.2011.105.


Antagonism by chlorisondamine and propranolol, but not by atenolol, of the circadian phase-dependent phentolamine-induced changes in the cardiac noradrenaline turnover in the rat.

Lemmer B, Charrier A Naunyn Schmiedebergs Arch Pharmacol. 1980; 313(3):205-12.

PMID: 7432552 DOI: 10.1007/BF00505735.


The effects of atenolol on spontaneous and reflex activity of the sympathetic nerves in the anaesthetized cat.

Scott E Br J Pharmacol. 1981; 73(3):609-16.

PMID: 7248661 PMC: 2071703. DOI: 10.1111/j.1476-5381.1981.tb16795.x.


Pharmacokinetics and pharmacodynamics of propranolol stereoisomers in hyperthyroid patients.

Tawara K, Kawashima K, Ishikawa H, Yamamoto K, Saito K, Ebihara A Eur J Clin Pharmacol. 1981; 19(3):197-203.

PMID: 6894282 DOI: 10.1007/BF00561949.